×
Sign in
Menu
Home
Resources
Back To Top
×
Contact the Presenter
×
Add To Cart
×
Test
ELCC Virtual 2021
Final Programme PDF
Advanced Search
24.03.2021
25.03.2021
26.03.2021
27.03.2021
Educational session
Industry Satellite Symposium
Keynote lecture
Multidisciplinary Tumour Board
Proffered Paper session
Special session
Virtual Lounge Discussion
Young oncologists
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
Channel 1
16:10(1h 30m)
AstraZeneca - Immuno-oncology treatment paradigms for first-line ES SCLC and unresectable stage III NSCLC
10:00(1h)
Lung cancer screening: The end of the beginning
12:50(1h 30m)
MSD - Defining the standard of care in lung cancer
09:10(35m)
Opening session and Heine H. Hansen Award lecture 2021
11:15(1h 20m)
Optimal management of patients with PDL1-high advanced NSCLC
14:35(1h 20m)
Proffered Paper session
Channel 2
16:10(1h 30m)
Bristol Myers Squibb - In-the-know with I-O: Clinical conversations and considerations for thoracic cancer treatments
12:50(1h 30m)
Novartis - Early treatment decisions in NSCLC: A debate on best practices
10:00(1h)
Novel therapeutic approaches: Exciting times in lung cancer
14:35(1h 20m)
Supportive care in the era of novel therapies for thoracic cancers (EONS & IASLC NAHP Committee)
11:15(1h 20m)
The eternal debate in stage III
Channel 3
16:10(1h 30m)
AstraZeneca - A European multidisciplinary perspective on evolving treatment practices in EGFRm NSCLC
14:35(1h 20m)
Lung cancer care needs (LuCE)
12:50(1h 30m)
Medscape Oncology Global - Advances in oncogene driven metastatic NSCLC: Focusing on EGFR Exon 20 insertions and ALK-Positive NSCLC
10:00(1h)
Mesothelioma: Will I-O shape the future?
11:15(1h 20m)
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start?
Lounge
18:00(1h)
Young Oncologists HowTo Session: Practical tips in managing older patients with lung cancer
×
Dialog
×
Sponsored Access
Access to the resources are offered to you by
ESMO Events